Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 Visualizzazioni
• 07/14/23
0
0
Incorporare
administrator
Iscritti
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti